Modern Healthcare May 15, 2020
Christie Rizk, Genomeweb

Contact tracing, epidemiological analyses, and genetic studies will be integral to re-opening the country during the pandemic. The large majority of SARS-CoV-2 tests have been PCR-based and work well to give a yes-or-no answer on whether a person is infected. However, they can’t really go much further into genetic and epidemiological analyses needed to getting the world back on its feet.

Next-generation sequencing (NGS) could fill the gap, and a recent case study from the pediatric intensive care unit at Children’s Hospital Los Angeles (CHLA) illustrates why NGS is ideal for the more detailed studies that will be needed in the future.

A patient at the hospital’s PICU and his mother showed signs of COVID-19 simultaneously with four healthcare workers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Public Health / COVID
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article